Howe & Rusling Inc Moderna, Inc. Transaction History

Howe & Rusling Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $118 - $194	1 Added 0.65%	155 $18,000
Q2 2022 Aug 15, 2022	BUY	$117.13 - $176.59 $468 - $706	4 Added 2.67%	154 $22,000
Q4 2020 Feb 08, 2021	BUY	$65.74 - $169.86 $3,286 - $8,493	50 Added 50.0%	150 $16,000
Q3 2020 Nov 06, 2020	BUY	$54.34 - $94.85 $271 - $474	5 Added 5.26%	100 $7,000
Q1 2020 May 14, 2020	SELL	$17.78 - $31.58 $3,733 - $6,631	-210 Reduced 68.85%	95 $3,000
Q4 2019 Feb 05, 2020	BUY	$13.93 - $21.28 $1,532 - $2,340	110 Added 56.41%	305 $6,000
Q3 2019 Oct 31, 2019	BUY	$12.26 - $18.07 $2,390 - $3,523	195 New	195 $3,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Howe & Rusling Inc, based on Form 13F filings with the SEC.

Stay updated on Howe & Rusling Inc with notifications on news.